1. Home
  2. CLPS vs ENLV Comparison

CLPS vs ENLV Comparison

Compare CLPS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CLPS Incorporation

CLPS

CLPS Incorporation

N/A

Current Price

$0.93

Market Cap

26.8M

Sector

Technology

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.97

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLPS
ENLV
Founded
2005
2005
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.8M
26.6M
IPO Year
2018
1995

Fundamental Metrics

Financial Performance
Metric
CLPS
ENLV
Price
$0.93
$0.97
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
26.3K
11.0M
Earning Date
10-17-2025
11-28-2025
Dividend Yield
14.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$164,481,414.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.17
N/A
52 Week Low
$0.82
$0.83
52 Week High
$1.88
$2.10

Technical Indicators

Market Signals
Indicator
CLPS
ENLV
Relative Strength Index (RSI) 49.98 46.57
Support Level $0.90 $0.88
Resistance Level $0.98 $1.06
Average True Range (ATR) 0.07 0.12
MACD 0.01 -0.00
Stochastic Oscillator 46.94 14.12

Price Performance

Historical Comparison
CLPS
ENLV

About CLPS CLPS Incorporation

CLPS Inc. is an IT consulting and solutions provider serving international clients in the banking, wealth management, e-commerce, and automotive sectors. The company drives digital transformation using AI, cloud computing, and big data, offering IT consulting, customized solutions, virtual banking training, recruitment, professional training, and software services. It operates mainly in two segments: IT services, which generate the majority of its revenue, and academic education services. The company has a presence in Hong Kong, Singapore, Mainland China, India, Malaysia, and Japan, with the majority of its revenue coming from Mainland China.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: